SCHEMBL787118

SCHEMBL787118

Cc1cccc(-c2ccc(Cl)c(C(=O)O)c2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 3/20 0.70
AKR1C1 Q04828 3/20 0.70
DHODH Q02127 2/20 0.52
GRIK1 P39086 1/20 0.51
GRIA1 P42261 1/20 0.51
GRIA2 P42262 1/20 0.51
GRIA3 P42263 1/20 0.51
GRIA4 P48058 1/20 0.51
GRIK2 Q13002 1/20 0.51
GRIK3 Q13003 1/20 0.51
MCL1 Q07820 3/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
XDH P47989 1/20 0.48
ERCC5 P28715 1/20 0.48
FEN1 P39748 1/20 0.48
CTSB P07858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ACMSD Q8TDX5 2/20 0.47
RPA1 P27694 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6508314 0.87 AKR1C2 (0.70) AKR1C2AKR1C1DHODHMCL1XDH
SCHEMBL28113573 0.85 AKR1C2 (0.56) AKR1C2AKR1C1DHODHERCC5FEN1
SCHEMBL122520 0.84 ACMSD (0.63) AKR1C2AKR1C1GRIK1GRIA1GRIA2
SCHEMBL2771204 0.84 ALDH1A1 (0.68) AKR1C2AKR1C1GRIK1GRIA1GRIA2
SCHEMBL15936129 0.83 ALDH1A1 (0.63) AKR1C2AKR1C1GRIK1GRIA1GRIA2
SCHEMBL787129 0.83 AKR1C2 (0.54) AKR1C2AKR1C1ALDH1A1ERCC5FEN1
SCHEMBL31312218 0.81 RXRA (0.62) GRIK1GRIA1GRIA2GRIA3GRIA4
SCHEMBL9850077 0.81 ACMSD (0.72) AKR1C2AKR1C1DHODHMCL1ACMSD
SCHEMBL2562897 0.81 EIF4E (0.56) AKR1C2AKR1C1GRIK1GRIA1GRIA2
SCHEMBL14783994 0.80 DCLRE1B (0.57) AKR1C2AKR1C1DHODHGRIK1GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025006553-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2025-01-02 WO disclosed
US-8748632-B2 Positive allosteric modulators of group II mGluRs SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-06-10 US disclosed
US-20120071503-A1 POSITIVE ALLOSTERIC MODULATORS OF GROUP II MGLURS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071503-A1 POSITIVE ALLOSTERIC MODULATORS OF GROUP II MGLURS GRM2, GRM1, GRIN2C AKR1C2 4832/4885AKR1C1 4866/4885DHODH 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.